Search

everythinglearnresearchcommunity

for

Search:↓

The patient's long-term symptoms were due to Sheehan's syndrome, which improved with hormone therapy.

SHBG may be a useful early indicator and treatment target for PCOS.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Lower SHBG levels may increase the risk of PCOS.

Pattern baldness is likely caused by a dominant gene influenced by testosterone levels, making it more common in men.

Hormone therapy for trans individuals is effective and generally safe in the short term.

High DHEA and short cervical length in women with PCOS and recurrent miscarriages may harm pregnancy outcomes.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Good nutrition is crucial for health and preventing disease, and supplements can help prevent nutrient deficiencies.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.